Generic pharma companies unlikely to be impacted by Trump's order to cut prescription drug prices: Report

Generic drug companies in India are not expected to be affected by US President Donald Trump's new order to bring the prices for prescription (Rx) drugs in line with other developed nations, according to a report by HDFC Securities.
Read more...